ASH Clinical News FINAL_ACN_3.14_FULL_ISSUE_DIGITAL | Page 11

VOLUME 03 | NUMBER 14 | DECEMBER 2017 Around the Network AMERICAN SOCIETY OF HEMATOLOGY (ASH) HEADQUARTERS 2021 L Street NW, Suite 900 Washington, DC 20036 www.hematology.org Tel: 202-776-0544 IN THIS ISSUE feature High Hopes EDITOR-IN-CHIEF Mikkael Sekeres, MD, MS Hematology patients are turning to cannabis for symptom relief, but should they? Vice-Chair for Clinical Research Director, Leukemia Program Cleveland Clinic, Taussig Cancer Institute Cleveland, OH 109 feature A World of Difference ASSOCIATE EDITORS Beth Faiman, CNP, PhD A look at the slow march to bring high-quality hematology and oncology care to limited-resource areas. Cleveland Clinic Cleveland, OH 118 Alice Ma, MD University of North Carolina School of Medicine Chapel Hill, NC clinical news David Steensma, MD Dana-Farber Cancer Institute Boston, MA Keith Stewart, MBChB, MBA Mayo Clinic Scottsdale, AZ PUBLISHER American Medical Communications (AMC) EDITORIAL MANAGING EDITORS Kristin Hubing, ASH Ariel Jones-DeMaio, AMC ASSOCIATE MANAGING EDITOR Kerri Fitzgerald, AMC EDITORIAL ASSOCIATE Laurie Adamson, ASH ART DIRECTOR Ari Mihos ASSISTANT ART DIRECTORS Charlene DePrizio John Salesi DIGITAL PROJECTS MANAGER Chris Gedikli ADVERTISING ACCOUNT MANAGERS Nick Luciano [email protected] Gene Conselyea [email protected] Sima Sherman [email protected] Recruitment advertising orders can be sent to: DIRECTOR, RECRUITMENT CLASSIFIEDS Lauren Morgan [email protected] Visit us at ashclinicalnews.org Follow us on Twitter @ASHClinicalNews ©2017 by the American Society of Hematology. All materials contained in this newsletter are protected by copyright laws and may not be used, reproduced, or oth- erwise exploited in any manner without the express prior written permission of ASH Clinical News. Any third-party materials communicated to ASH Clinical News become its copyrighted property and may be used, reproduced, or otherwise exploited by ASH Clinical News. ASHClinicalNews.org 44 E  xamining Infection Risks of Anti-CD19 Gun Violence: A Public Health Crisis Does the oath to “do no harm” conflict with the right to bear arms? Physicians weigh in on the gun control debate. CAR T-Cell Therapies 58 Higher Cancer Risk Among Patients With Pregnancy-Related Venous Thromboembolism 83  On Location: 2017 ASH Annual Meeting Inside Look 113 ASHCLINICALNEWS.ORG @ASHCLINICALNEWS With nearly 5,000 abstracts and more than 150 sessions, the 59th ASH Annual Meeting & Exposition is jam-packed with practice-changing science, educational activities, and networking opportunities. Follow us on Twitter for on-site updates from the annual meeting: @ASHClinicalNews. Can’t make it to every session? ASH Clinical News will be your eyes and ears! Check our “On Location” section for daily updates from the meeting: ashclinicalnews.org/on-location. Sign up to receive our e-newsletters to have news from the annual meeting delivered to your inbox: ashclinicalnews.org/ enewsletter-sign-up. Watch our exclusive interviews with presenters and experts in our “Multimedia” section: ashclinicalnews.org/multimedia/exclusive-videos. “YOU MAKE THE CALL” WINNER Announcing last month’s “You Make the Call: Readers’ Response” winner: Nalini Janakiraman, MD Hope you enjoy your prize! Subscription inquiries should be sent to: [email protected] All correspondence for the American Society of Hematology should be sent to: American Society of Hematology, 2021 L Street NW, Suite 900, Washington DC 20036. Neither the American Society of Hematology nor the publisher is responsible for statements made by any editor or contributor. Statements, editorials, or opinions expressed in ASH Clinical News magazine do not necessarily represent official policy of the American Society of Hematology unless so stated. No responsibility is as- sumed by the American Society of Hematology or the Publisher for any injury or damage to persons or property as a matter of product liability, negligence or otherwise or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Although all advertising material published in ASH Clinical News magazine is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement by the American Society of Hematology or the Publisher of the quality or value of such product or of the claim made of it by its manufacturer. About the American Society of Hematology The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology. ASH Clinical News (ISSN 2375-8120) is published once per month by American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. Periodicals postage is pending/paid at Manalapan, NJ and additional mailing offices. POSTMASTER: Send address changes to American Medical Communications, 630 Madison Avenue, 2nd Floor, Manalapan, NJ 07726. ©Copyright, 2017. ASH Clinical News 9